Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$0.05 - $1.7 $978,785 - $33.3 Million
-19,575,710 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$7.2 - $16.82 $1.55 Million - $3.62 Million
215,000 Added 1.11%
19,575,710 $159 Million
Q2 2020

Aug 13, 2020

BUY
$4.62 - $8.01 $9.24 Million - $16 Million
2,000,000 Added 11.52%
19,360,710 $144 Million
Q1 2019

May 14, 2019

BUY
$12.71 - $15.0 $221 Million - $260 Million
17,360,710 New
17,360,710 $252 Million

Others Institutions Holding KLDO

# of Institutions
1
Shares Held
2.3K
Call Options Held
0
Put Options Held
0

About Kaleido Biosciences, Inc.


  • Ticker KLDO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,622,600
  • Description
  • Kaleido Biosciences, Inc., a clinical-stage healthcare company, develops microbiome metabolic therapies. The company develops KB195 for the treatment of patients with urea cycle disorder; KB295 to treat ulcerative colitis; KB174 for the treatment of hepatic encephalopathy; and KB109 to treat COVID-19 disease. It also develops programs for the tr...
More about KLDO
Track This Portfolio

Track Flagship Pioneering Inc. Portfolio

Follow Flagship Pioneering Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Flagship Pioneering Inc., based on Form 13F filings with the SEC.

News

Stay updated on Flagship Pioneering Inc. with notifications on news.